EGFR and nasopharyngeal carcinoma: Previous meta-analyses[20–22] showed that EGFR overexpression predicted unfavorable overall survival (OS) and disease-free survival (DFS) but did not correlate with the absence of distant metastasis in patients with nasopharyngeal carcinoma.